On August 11, Talen rose 5.15% in regular trading, trading at approximately $360.36/share, with turnover of $70.89 million. The stock continued to recover following its Q2 earnings release on August 5, as analysts maintained bullish outlooks despite a significant earnings miss.

Talen reported a Q2 loss of $2.00 per share, far below the FactSet consensus estimate of $3.21 EPS. Revenue came in at $747 million, missing the $823 million estimate, though it still represented growth from $630 million a year earlier. Despite the shortfall, Oppenheimer maintained its Outperform rating and adjusted its price target to $400 from $440. The FactSet consensus mean target stands at $479.20, implying significant upside from current levels.

Fundamentally, the company has hedged 85% of its expected generation for the current year and reiterated full-year adjusted EBITDA guidance of $17.5 billion to $20.5 billion, along with adjusted free cash flow of $9.8 billion to $11.8 billion, providing earnings visibility that supports the ongoing price recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)